Clinical trials
Phase 1/2 Esophageal Squamous Cell Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 7 |
| Unknown status | 6 |
| Completed | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| DualityBio Inc. | 1 |
| Jacobio Pharmaceuticals Co., Ltd. | 1 |
| Jiangsu Cancer Institute & Hospital | 1 |
| Peking University | 1 |
| Qiu Guoqin | 1 |
| Shanghai Chest Hospital | 1 |
| Shanghai Junshi Bioscience Co., Ltd. | 1 |
| Sichuan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 16 |
| Esophageal Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Squamous Cell | 1 |
| Esophageal Diseases | 1 |
| Melanoma | 1 |
| Nasopharyngeal Carcinoma | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.